Marinus Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRNS research report →
Companymarinuspharma.com
Marinus Pharmaceuticals, Inc. , a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings.
- CEO
- Scott N. Braunstein
- IPO
- 2014
- Employees
- 165
- HQ
- Radnor, PA, US
Price Chart
Valuation
- Market Cap
- $30.37M
- P/E
- -0.21
- P/S
- 0.98
- P/B
- 1.76
- EV/EBITDA
- -0.16
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 93.76%
- Op Margin
- -424.30%
- Net Margin
- -456.31%
- ROE
- -213.02%
- ROIC
- -89.82%
Growth & Income
- Revenue
- $30.99M · 21.63%
- Net Income
- $-141,405,000 · -613.59%
- EPS
- $-2.63 · -415.69%
- Op Income
- $-131,485,000
- FCF YoY
- -3.02%
Performance & Tape
- 52W High
- $10.50
- 52W Low
- $0.22
- 50D MA
- $0.43
- 200D MA
- $1.06
- Beta
- 1.26
- Avg Volume
- 1.81M
Get TickerSpark's AI analysis on MRNS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 7, 25 | Ezickson Elan | sell | 8,600 |
| Feb 11, 25 | Ezickson Elan | sell | 10,450 |
| Feb 11, 25 | Ezickson Elan | sell | 12,375 |
| Feb 11, 25 | Ezickson Elan | sell | 16,500 |
| Feb 11, 25 | Ezickson Elan | sell | 20,900 |
| Feb 11, 25 | Ezickson Elan | sell | 16,200 |
| Feb 11, 25 | Ezickson Elan | sell | 25,000 |
| Feb 11, 25 | Ezickson Elan | sell | 2,300 |
| Feb 7, 25 | Fischer Seth H. Z. | sell | 12,707 |
| Feb 11, 25 | Fischer Seth H. Z. | sell | 16,200 |
Our MRNS Coverage
We haven't published any research on MRNS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MRNS Report →